Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 30;10(1):5678.
doi: 10.1038/s41598-020-62418-9.

Significance of Clostridium difficile in community-acquired diarrhea in a tertiary care center in Lebanon

Reem Al Assaad  1 , Alik Dakessian  1 , Rana Bachir  1 , Abdul Rahman Bizri  2 , Mazen El Sayed  3   4
Affiliations

Significance of Clostridium difficile in community-acquired diarrhea in a tertiary care center in Lebanon

Reem Al Assaad et al. Sci Rep. .

Abstract

Clostridium difficile infection (CDI) is becoming a cause of community-acquired diarrhea. The aim is to describe (CDI) as a cause of acute diarrhea in patients presenting from the community to the Emergency Department (ED) of a tertiary care center in Lebanon. A retrospective study conducted in the ED at the American University of Beirut Medical Center (AUBMC). Adult patients presenting with the chief complaint of diarrhea and having positive CDI by stool laboratory testing (toxins A and B), during a three-year period were included. 125 patients with CDI were included. Average age was 61.43 (±20.42) with roughly equal sex prevalence. 30% (n = 36) of patients had neither antibiotic exposure nor recent hospitalization prior to current CDI. Mortality was 9.6% (n = 12), CDI was attributed as the cause in 16.7% (n = 2) and a contributing factor in 41.6% (n = 5). Recurrence within 3 months occurred in 9.6% (n = 11) in mainly those taking Proton Pump Inhibitors (PPIs) and having multiple co-morbidities. There is a high rate of community acquired CDI in Lebanon. Review of patients' medications (PPIs and antibiotics) is crucial. More studies are needed to assess mortality associated with CDI and the outcome of coinfection with other enteric pathogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Inclusion and Exclusion Flowchart.
See this image and copyright information in PMC

References

    1. Voth DE, Ballard JD. Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clin. Microbiol. Rev. 2005;18:247–263. doi: 10.1128/CMR.18.2.247-263.2005. - DOI - PMC - PubMed
    1. Yoo J, Lightner AL. Clostridium difficile Infections: What Every Clinician Should Know. Perm. J. 2010;14:35–40. doi: 10.7812/TPP/10-001. - DOI - PMC - PubMed
    1. Pituch H. Clostridium difficile is no longer just a nosocomial infection or an infection of adults. Int. J. Antimicrob. Agents. 2009;33:42–45. doi: 10.1016/S0924-8579(09)70016-0. - DOI - PubMed
    1. Levy AR, et al. Incidence and Costs of Clostridium difficile Infections in Canada. Open. Forum Infect. Dis. 2015;2:ofv076. doi: 10.1093/ofid/ofv076. - DOI - PMC - PubMed
    1. Bauer MP, et al. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage–two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth. J. Med. 2008;66:207–211. - PubMed

MeSH terms